PCI for coronary chronic total occlusion significantly improves angina symptom scores compared with placebo in patients with ...

Percutaneous coronary intervention successfully alleviated chest pain symptoms in select patients with chronic total occlusion and reduced the frequency of anginal events, a speaker ...

People who have had a heart attack may be able to safely discontinue beta-blocker use after a year if they are at low-risk ...

Chest pain may still be angina even when the main heart arteries look clear. Using cardiac stress MRI (a heart scan that measures blood flow with magnetic resonance imaging), testing uncovered small ...

Please provide your email address to receive an email when new articles are posted on . In patients with heart attack without blocked arteries, a stratified treatment ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Calgary, Alberta--(Newsfile Corp. - October 15, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ ...

People with chronic chest pain who received a coronary sinus reducer (CSR)—a stent thought to increase the amount of oxygen-rich blood flowing to the heart muscle—experienced significant reductions in ...

Calgary, Alberta--(Newsfile Corp. - September 16, 2025) - Hemostemix Inc. (HEM:CA) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ ...